Treatment Types
Treatment Types
Weight-loss surgery volumes fell over 20% (2022-2024) as GLP-1 drugs displace bariatric procedures
US weight-loss surgery procedures dropped more than 20% between 2022 and 2024, falling below 200,000 for the first time this decade, as patients increasingly turn to GLP-1 medications like Ozempic and Zepbound; Mexican bariatric facilities are adapting their marketing to this shift.
6 min read
Treatment Types
GLP-1-driven body-contouring surgery demand surge: 800k+ patients, 20% already operated
Over 800,000 aesthetic patients have used GLP-1 drugs; 20% have already undergone plastic surgery (largely body contouring after weight loss) and 39% are considering it -- a new, specific demand pipeline into cosmetic-surgery medical tourism.
5 min read